This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Erythrocytic schizogony

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

In this phase the red blood cells become infected by the micromerozoites. While in the red blood cells the micromerozoites pass through several stages of develop until they finally develop into merozoites. This asexual parasitic form is present at a variable time from when the human was inoculated with the sporozoite. In P.vivax this occurs at about 12 days, in P. falciparum about 9 days.

The red blood cells that are invaded is dependent on which form of Plasmodium the patient has been inoculated with. P. falciparum invades all red blood cells. P. vivax and P. ovale preferentially invade young red blood cells and reticulocytes. P. malariae preferentially invades senescent red blood cells.

The merozoites then go through a cycle of where they pass through the various stages of development to produce more merozoites. As each cycle terminates the red cells are ruptured and the merozoite are released into the circulation. The merozoites then may invade more red blood cells and the cycle continues again. The cycle occurs approximately every 48 hours in P. falciparum infection, every 48-72 hours in P. vivax and P. ovale, and every 72 hours in P. malariae infection.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.